Oncological safety of omitting axillary nodal clearance in breast cancer patients Post- Neoadjuvant chemotherapy (NACT) with complete pathological response: A retrospective analysis

被引：0
|
作者：
Chougle, Q. [1 ]
Vaidhyakkaran, I. [1 ]
Saleeb, A. [1 ]
Kalyvioti, C. [1 ]
Hamed, H. [1 ]
机构：
[1] Guys & St Thomas NHS Trust, Breast Surg, London, England
来源：
BREAST | 2025年 / 80卷
关键词：
D O I：
10.1016/j.breast.2025.104216
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P398
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Predictive factors of an axillary pathological complete response of node-positive breast cancer to neoadjuvant chemotherapy
    Naoko Iwamoto
    Tomoyuki Aruga
    Shinichiro Horiguchi
    Chiaki Saita
    Mai Onishi
    Risa Goto
    Toshiyuki Ishiba
    Yayoi Honda
    Hiromi Miyamoto
    Katsumasa Kuroi
    Surgery Today, 2020, 50 : 178 - 184
  • [22] Pathological complete response and associated factors in breast cancer after neoadjuvant chemotherapy: A retrospective study
    Gundogdu, Adnan
    Ulusahin, Mehmet
    Cekic, Arif Burak
    Kazaz, Seher Nazli
    Guner, Ali
    TURKISH JOURNAL OF SURGERY, 2024, 40 (01) : 73 - 81
  • [23] Pathological response and surgical outcome with neoadjuvant chemotherapy (NACT) in Saudi Arabian breast cancer (BC) patients.
    Abdelrahman, Hossam A.
    Hadedeyah, Deena
    Ur-Rehman, Habib
    Karim, Syed Mustafa
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients With Locally Advanced Breast Cancer and Partial Response After Neoadjuvant Chemotherapy
    Pellicciaro, Marco
    Materazzo, Marco
    Buonomo, Chiara
    Vanni, Gianluca
    IN VIVO, 2021, 35 (04): : 2489 - 2494
  • [25] Predictive factors for axillary pathological complete response to neoadjuvant therapy in elderly breast cancer patients
    Wang, Yuying
    Wang, Rui
    Lu, Di
    Zeng, Yaling
    Tu, Xihui
    Liu, Shiwei
    Zhang, Purong
    BMC CANCER, 2025, 25 (01)
  • [26] Association between pretreatment neutrophil to lymphocyte ratio (NLR) and complete pathological response (pCR) in breast cancer patients treated with neoadjuvant chemotherapy (NACT).
    Clarke, Kaethe Vivienne
    Amir, Eitan
    Berman, Hal K.
    Maganti, Manjula
    Sridhar, Srikala S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] Predicting pathological complete response (pCR) to neoadjuvant chemotherapy (NACT) based on pre- and post-NACT digital mammography and digital breast tomosynthesis findings
    Agarwal, G.
    Sonthineni, C.
    Mohindra, N.
    Jain, N.
    Neyaz, Z.
    Agrawal, V.
    Krishnani, N.
    Maylivahnan, S.
    Mishra, A.
    Lal, P.
    CANCER RESEARCH, 2019, 79 (04)
  • [28] PROGESTERONE RECEPTOR (PR) NEGATIVITY PREDICTS PATHOLOGICAL COMPLETE RESPONSE (PCR) AFTER NEOADJUVANT CHEMOTHERAPY (NACT) IN BREAST CANCER (BC) PATIENTS (PTS)
    Perez-Garcia, J. M.
    Saura, C.
    Munoz, E.
    Sanchez-Olle, G.
    Gomez, P.
    Di Cosimo, S.
    Sabadell, D.
    Cortes, J.
    Baselga, J.
    Bellet, M.
    ANNALS OF ONCOLOGY, 2009, 20 : 53 - 54
  • [29] Prediction of pathological complete response by microRNA in breast cancer patients treated with neoadjuvant chemotherapy
    Shimomura, Akihiko
    Shiino, Sho
    Kawauchi, Junpei
    Takizawa, Satoko
    Ichikawa, Makiko
    Matsuzaki, Juntaro
    Sakamoto, Hiromi
    Kinoshita, Takayuki
    Tamura, Kenji
    Ochiya, Takahiro
    CANCER SCIENCE, 2018, 109 : 394 - 394
  • [30] MRI in diagnosis of pathological complete response in breast cancer patients after neoadjuvant chemotherapy
    Li, Yan-Ling
    Zhang, Xiao-Peng
    Li, Jie
    Cao, Kun
    Cui, Yong
    Li, Xiao-Ting
    Sun, Ying-Shi
    EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (02) : 242 - 249
12345